Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 2.21 ($0.03) and last traded at GBX 3 ($0.04), with a volume of 579069 shares. The stock had previously closed at GBX 6.12 ($0.08).
Celadon Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 196.67, a current ratio of 1.92 and a quick ratio of 6.97. The firm has a market capitalization of £3.32 million, a P/E ratio of -0.68 and a beta of -0.26. The company’s 50 day moving average price is GBX 16.17 and its 200 day moving average price is GBX 20.88.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Short Nasdaq: An Easy-to-Follow Guide
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
